NOVN.SW NOVARTIS N | CH0012005267
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 60.990.427.100 | 57.513.569.370 | 6.05% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 9,80 | 8,77 | 11.71% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 20 | 20 | 0.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |